Caxton Associates (New York)’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,474
Closed -$166K 516
2023
Q3
$166K Buy
+13,474
New +$166K 0.02% 362